<table width="80%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 3: Subgroup Analyses of Mortality and Hospitalization During the First Two Years Following Randomization</caption>
<col span="1"></col>
<col span="1"></col>
<col span="1"></col>
<col span="1"></col>
<col span="1"></col>
<tbody>
<tr>
<td> </td>
<td>
<content stylecode="bold"> </content>
</td>
<td>
<content stylecode="bold">Risk of All-Cause Mortality or<br/>All-Cause Hospitalization<linkhtml href="#footnote-4">*</linkhtml>
</content>
</td>
</tr>
<tr>
<td>
<content stylecode="bold"> </content>
</td>
<td>
<content stylecode="bold"> n</content>
</td>
<td>
<content stylecode="bold">Placebo</content>
</td>
<td>
<content stylecode="bold"> Digoxin</content>
</td>
<td>
<content stylecode="bold">Relative risk<linkhtml href="#footnote-5">†</linkhtml>
</content>
</td>
</tr>
<tr>
<td>All patients<br/>(EF ≤0.45)</td>
<td>6801</td>
<td>604</td>
<td>593</td>
<td>0.94<br/>(0.88-1.00)</td>
</tr>
<tr>
<td>NYHA I/II<br/>EF 0.25-0.45<br/>CTR ≤0.55</td>
<td>4571<br/>4543<br/>4455</td>
<td>549<br/>568<br/>561</td>
<td>541<br/>571<br/>563</td>
<td>0.96 (0.89-1.04)<br/>0.99 (0.91-1.07)<br/>0.98 (0.91-1.06)</td>
</tr>
<tr>
<td>NYHA III/IV<br/>EF &lt;0.25<br/>CTR &gt;0.55</td>
<td>2224<br/>2258<br/>2346</td>
<td>719<br/>677<br/>687</td>
<td>696<br/>637<br/>650</td>
<td>0.88 (0.80-0.97)<br/>0.84 (0.76-0.93)<br/>0.85 (0.77-0.94)</td>
</tr>
<tr>
<td>EF &gt;0.45<linkhtml href="#footnote-6">‡</linkhtml>
</td>
<td>987</td>
<td>571</td>
<td>585</td>
<td>1.04 (0.88-1.23)</td>
</tr>
<tr>
<td> </td>
<td> </td>
<td>
<content stylecode="bold">Risk of HF-Related Mortality or<br/>HF-Related Hospitalization<footnoteref idref="FOOT_3765"></footnoteref>
</content>
</td>
</tr>
<tr>
<td>
<content stylecode="bold"> </content>
</td>
<td>
<content stylecode="bold">n</content>
</td>
<td>
<content stylecode="bold">Placebo</content>
</td>
<td>
<content stylecode="bold">Digoxin</content>
</td>
<td>
<content stylecode="bold">Relative risk<footnoteref idref="FOOT_3766"></footnoteref>
</content>
</td>
</tr>
<tr>
<td>All patients<br/>(EF ≤0.45)</td>
<td>6801</td>
<td>294</td>
<td>217</td>
<td>0.69 (0.63-0.76)</td>
</tr>
<tr>
<td>NYHA I/II<br/>EF 0.25-0.45<br/>CTR ≤0.55</td>
<td>4571<br/>4543<br/>4455</td>
<td>242<br/>244<br/>239</td>
<td>178<br/>190<br/>180</td>
<td>0.70 (0.62-0.80)<br/>0.74 (0.66-.084)<br/>0.71 (0.63-0.81)</td>
</tr>
<tr>
<td>NYHA III/IV<br/>EF &lt;0.25<br/>CTR &gt;0.55</td>
<td>2224<br/>2258<br/>2346</td>
<td>402<br/>394<br/>398</td>
<td>295<br/>270<br/>287</td>
<td>0.65 (0.57-0.75)<br/>0.61 (0.53-0.71)<br/>0.65 (0.57-0.75)</td>
</tr>
<tr>
<td>EF &gt;0.45<footnoteref idref="FOOT_3767"></footnoteref>
</td>
<td>987</td>
<td>179</td>
<td>136</td>
<td>0.72 (0.53-0.99)</td>
</tr>
<tr>
<td>
<br/>
</td>
</tr>
</tbody>
</table>